These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28814738)

  • 41. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
    Segersten U; Björklund P; Hellman P; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D receptor agonists' anti-inflammatory properties.
    Vojinovic J
    Ann N Y Acad Sci; 2014 May; 1317():47-56. PubMed ID: 24754474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.
    Wu-Wong JR; Chen YW; Nakane M; Wolf M
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):215-22. PubMed ID: 21424825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.
    Wu-Wong JR; Kawai M; Chen YW; Nakane M
    Br J Pharmacol; 2011 Sep; 164(2b):551-60. PubMed ID: 21557735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia.
    Sato M; Lu J; Iturria S; Stayrook KR; Burris LL; Zeng QQ; Schmidt A; Barr RJ; Montrose-Rafizadeh C; Bryant HU; Ma YL
    J Bone Miner Res; 2010 Jun; 25(6):1326-36. PubMed ID: 20200930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro.
    Fleet JC; Bradley J; Reddy GS; Ray R; Wood RJ
    Arch Biochem Biophys; 1996 May; 329(2):228-34. PubMed ID: 8638956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice.
    Chow EC; Durk MR; Maeng HJ; Pang KS
    Biopharm Drug Dispos; 2013 Oct; 34(7):402-16. PubMed ID: 23897575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.
    Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P
    J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of vitamin D receptor ligands with cell-specific and dissociated activity.
    Castillo AI; Sánchez-Martínez R; Jiménez-Lara AM; Steinmeyer A; Zügel U; Aranda A
    Mol Endocrinol; 2006 Dec; 20(12):3093-104. PubMed ID: 16901972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
    Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
    Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).
    Maggi M; Crescioli C; Morelli A; Colli E; Adorini L
    J Endocrinol Invest; 2006; 29(7):665-74. PubMed ID: 16957418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term vitamin D deficiency in older adult C57BL/6 mice does not affect bone structure, remodeling and mineralization.
    van der Meijden K; Buskermolen J; van Essen HW; Schuurman T; Steegenga WT; Brouwer-Brolsma EM; Langenbach GEJ; van Ruijven LJ; den Heijer M; Lips P; Bravenboer N
    J Steroid Biochem Mol Biol; 2016 Nov; 164():344-352. PubMed ID: 26361014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis.
    Kang ZS; Wang C; Han XL; Du JJ; Li YY; Zhang C
    Eur J Med Chem; 2018 Feb; 146():541-553. PubMed ID: 29407979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction.
    Panda DK; Miao D; Tremblay ML; Sirois J; Farookhi R; Hendy GN; Goltzman D
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7498-503. PubMed ID: 11416220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.